Anne O’Dea

Articles by Anne O’Dea

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE

BySherene Loi, MD, PhD,Erica Stringer-Reasor,Jean-Sebastien Frenel,Mattea Reinisch,Ruth M. O’Regan,Michelino De Laurentiis,Yeon Hee Park,Anne O’Dea,Yen-Shen Lu,Valeria Gonzalez,Melissa Gao,Sorcha Waters,Huilin Hu,Binghe Xu

June 24th 2025

Latest Updated Articles

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE
June 24th 2025

Trending on CancerNetwork

FDA Approves SC Amivantamab for Recurrent/Metastatic HNSCC

Setting Up an HDR Brachytherapy Program Amid a National Decline

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

CD38-Targeted Immuno-PET Helps Detect Active Multiple Myeloma

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer